X

Vous n'êtes pas connecté

  - FACTPATROL.COM - A La Une - 22/Aug 08:17

New hope for glioblastoma multiforme therapy

Glioblastoma multiforme (GBM) is the most aggressive and common type of brain tumour, affecting nearly 250,000 people worldwide every year. Despite decades of research, there is still no cure. Standard treatment involves surgical removal of the tumour, followed by radiotherapy and chemotherapy. While these approaches can temporarily slow tumour growth, the average life expectancy for […]

Articles similaires

Sorry! Image not available at this time

New hope for glioblastoma multiforme therapy

factpatrol.com - 22/Aug 08:17

Glioblastoma multiforme (GBM) is the most aggressive and common type of brain tumour, affecting nearly 250,000 people worldwide every year. Despite...

New drug could slow aggressive brain cancer recurrence

knowridge.com - 12/Aug 09:57

Glioblastoma is one of the deadliest forms of brain cancer. Even with surgery, radiation, and chemotherapy, it almost always comes back. Most patients...

New drug could slow aggressive brain cancer recurrence

knowridge.com - 12/Aug 09:57

Glioblastoma is one of the deadliest forms of brain cancer. Even with surgery, radiation, and chemotherapy, it almost always comes back. Most patients...

Blocking brain damage may slow aggressive glioblastoma growth

news.medical.net - 20/Aug 18:44

Blocking brain damage triggered by a glioblastoma, an aggressive brain cancer, may slow the growth of the cancer and allow the brain to keep working...

Sorry! Image not available at this time

CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update

wn.com - 15/Aug 14:21

Strong cash position of $12.1 million expected to fund operations into the second half of 2026 Driving lead program, TPI 287, towards Phase 2 study...

Sorry! Image not available at this time

CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update

wn.com - 15/Aug 14:21

Strong cash position of $12.1 million expected to fund operations into the second half of 2026 Driving lead program, TPI 287, towards Phase 2 study...

Breathing dirty air? It may raise the risk of meningioma

oncologynews.com.au - 10/Aug 21:43

People exposed to higher levels of air pollution may be more likely to develop meningioma, a typically noncancerous brain tumour, according to a large...

Breathing dirty air? It may raise the risk of meningioma

oncologynews.com.au - 10/Aug 21:43

People exposed to higher levels of air pollution may be more likely to develop meningioma, a typically noncancerous brain tumour, according to a large...

Dual immune checkpoint inhibition with radiotherapy does not improve progression-free survival for patients with newly diagnosed MGMT-unmethylated glioblastoma

oncologynews.com.au - 01:11

NRG Oncology recently reported the results of the National Cancer Institute-sponsored phase II/III NRG-BN007 clinical trial showing that combining...

Zombie cancer cells give cold shoulder to chemotherapy

oncologynews.com.au - 01:29

Cancer is the leading cause of disease-related death in childhood. This is in part due to cancer-associated genes called oncogenes that can be found...